Insider filing · EVMN
Kyle Carver
Chief Financial Officer
profile →
Evommune, Inc.
EVMN · Healthcare · 11 filings in 24 months
ticker →
Kyle Carver sold $415K of Evommune (EVMN)
Executed May 28, disclosed Jun 1, 4 days later.
Value, as filed
$415K
18,175 sh × $22.84
Executed
May 28
the trade date, as filed
Disclosed
Jun 1
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
KCKyle Carver (Chief Financial Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Evommune, Inc. (EVMN). The largest single filing was $415K of EVMN (18,175 sh × $22.84, as filed), executed May 28.
The name
EVMNHealthcare · Evommune, Inc. operates as a clinical-stage biotechnology company in the United States
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→